<DOC>
	<DOCNO>NCT00230737</DOCNO>
	<brief_summary>This study determine whether melatonin tablet increase sleep old adult insomnia .</brief_summary>
	<brief_title>Effects Melatonin Insomnia Symptoms Older Adults</brief_title>
	<detailed_description>Melatonin hormone secrete predominantly sleep period , suspect strong link circadian sleep-wake cycle . Melatonin also available pill form , administer day , tend sedative effect . Clinical trial examine nocturnal effect melatonin focused patient age insomnia , regardless endogenous melatonin level . Data indicate , however , individual low endogenous melatonin level may responsive exogenous melatonin . Generally , melatonin level decrease age ; therefore , old individual insomnia represent ideal population study effect exogenous melatonin sleep . This study provide old adult insomnia melatonin tablet determine whether tablet increase sleep . Participation study last 10 week comprise overnight visit 2 timepoints , begin Week 1 end Week 6 . At study entry , participant admit General Clinical Research Center 3-night stay , begin overnight urine screen confirm low melatonin level . Participants also ask begin sleep diary documenting sleep quality quantity ; diary use throughout study . During Night 1 clinic , participant urine sample collect throughout night . Night 2 adaptation night allow participant get use surroundings . On Night 3 , participant sensor attach body polysomnograph machine use measure sleep efficiency . Participants sleep efficiency 80 % high complete study participation . Participants sleep efficiency less 80 % randomly assign one three study treatment daily 6 week : high-dose melatonin ( 4.0 mg ) , low-dose melatonin ( 0.4 mg ) , placebo . Participants study visit Weeks 1 , 3 , 6 monitor adverse event . After 6 week , participant 2 overnight clinic visit identical Nights 2 3 beginning study . Sleep questionnaire , cognitive test , psychomotor test use assess participant begin study , 6 week , end study . One month end study , participant follow-up visit reassess adverse event .</detailed_description>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>History insomnia Low melatonin level study entry History sleep apnea ( temporary cessation breathe sleep ) Diagnosis restless legs syndrome Current alcohol substance abuse Dementia Anemia Liver disease Leukemia lymphoma Asthma</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Aged</keyword>
	<keyword>Sleep</keyword>
	<keyword>Insomnia</keyword>
	<keyword>Melatonin</keyword>
	<keyword>Neurobehavioral Manifestations</keyword>
	<keyword>Circadian Rhythms</keyword>
	<keyword>Human</keyword>
	<keyword>Polysomnography</keyword>
	<keyword>Elderly</keyword>
</DOC>